Analyst Sees This Kidney Disease Company's Stock Could Rise Sixfold, But Lists Two Issues
November 18, 2022 at 06:43 AM EST
Piper Sandlerraised its price target onArdelyx Inc(NASDAQ: ARDX) to $8 from $3 and upgraded toOverweight from ...